ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,804Medicare Part D Prescriptions Filled, Including Refills

Rank: 153 out of 973

$430K Total Retail Price of All Prescriptions

Rank: 205 out of 973

336 Patients Receiving at Least One Drug in Part D
69%Patients 65 Years and Older
61% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kansas
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 336 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

19% of this provider’s 336 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

4% of this provider’s 5,842 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kansas
LEVOTHYROXINE SODIUM 354 185 1 2
FUROSEMIDE 353 235 2 6
HYDROCODONE-ACETAMINOPHEN 325 181 S3 3 4
ATENOLOL 278 168 4 16
POTASSIUM CHLORIDE 275 175 5 9
LISINOPRIL 261 159 6 3
TRAMADOL HCL 251 125 7 18
OMEPRAZOLE 249 149 8 5
NAPROXEN 211 123 9 94
RANITIDINE HCL 207 67 10 45
SIMVASTATIN 200 137 11 1
METFORMIN HCL 187 147 12 8
AMLODIPINE BESYLATE 129 93 13 7
PAROXETINE HCL 127 71 14 66
GABAPENTIN 114 66 15 12
PREDNISONE 108 75 16 33
CLONIDINE HCL 101 59 17 67
LOVASTATIN 99 52 18 38
MELOXICAM 98 54 19 23
IBUPROFEN 94 73 20 102
WARFARIN SODIUM 89 72 21 10
SINGULAIR 89 45 21 106
ALLOPURINOL 88 65 23 29
CARVEDILOL 85 52 24 27
CARISOPRODOL 79 13 R 25 107
NEXIUM 72 36 26 30
AMOXICILLIN 71 31 27 101
POLYETHYLENE GLYCOL 3350 71 38 27 36
ACTOS 69 57 29 119
PHENYTOIN SODIUM EXTENDED 69 21 29 141
MORPHINE SULFATE ER 68 21 S2 31 74
CYMBALTA 68 64 31 40
CIPROFLOXACIN HCL 65 41 33 57
LYRICA 64 15 34 118
FENTANYL 59 38 S2 35 53
DICLOFENAC SODIUM 59 45 35 108
SERTRALINE HCL 57 26 37 21
NAMENDA 57 57 37 31
METOPROLOL TARTRATE 56 51 39 13
GLYBURIDE 55 52 R 40 59
CLOTRIMAZOLE-BETAMETHASONE 54 36 41 164
METOCLOPRAMIDE HCL 54 28 41 93
OXYBUTYNIN CHLORIDE 53 21 43 92
ENALAPRIL MALEATE 52 52 44 55
BUPROPION HCL 52 35 44 235
ZOLPIDEM TARTRATE 52 12 44 20
GLYBURIDE MICRONIZED 52 42 R 44 232
TRIAMTERENE-HCTZ 51 27 48 51
PANTOPRAZOLE SODIUM 51 36 48 37
DIOVAN 51 27 48 63
HYDROCHLOROTHIAZIDE 51 44 48 11
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 22, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.